Engineered APP C-terminus Alters Its Native Transcript Dynamics in Differentiated SH-SY5Y-Derived Neurons
Molecular Neurobiology · 2026-01 · 63 (1)
DOI: 10.1007/s12035-026-05928-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, online erschienen am 19.05.2026. Verfasst von D Chanuka M Kulatunga und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Science and Biotechnology, Chungnam National University, Yuseong-Gu, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Amyloid beta-Protein Precursor, Neurons, Cell Differentiation, Protein Engineering. Die Arbeit nennt 59 Literaturangaben.
Abstract (Originalsprache)
Alzheimer’s disease (AD) pathology is deeply connected with the processing of amyloid precursor protein (APP) and its cleavage products. APP processing generates functional fragments, such as the APP intracellular domain (AICD) and the APP carboxy-terminal fragment (CTF), which have been implicated in transcriptional regulation. However, their potential role in modulating endogenous APP splicing and expression remains unclear. This study investigates the self-regulatory potential of APP through its C-terminal fragments. Stable transgenic SH-SY5Y lines overexpressing APP695, its Swedish mutant form, and truncated and engineered C-terminal constructs were generated. They were differentiated over 24 days to get mature neuron-like cells and analyzed for APP transcript variants. The overexpression of APP fragments altered total APP levels and specific transcript variants, especially APPv3 and APPv11, predominantly in differentiated neurons. Differential splicing patterns were further confirmed through specific transcript fragment-size analysis. These findings highlight that APP derivatives actively influence transcriptional regulation and alternative splicing of native APP. This research advances our understanding of APP biology by revealing its self-regulatory complexity, suggesting that APP fragments could serve as transcription modulators of APP itself, providing insights into disease pathogenesis and novel therapeutic strategies in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Science and Biotechnology, Chungnam National University, Yuseong-Gu, Daejeon, Republic of Korea.
- Stem Cell Research Team, MK Biotech Inc, Yuseong-Gu, Daejeon, Republic of Korea.
- Department of Animal Science and Biotechnology, Chungnam National University, Yuseong-Gu, Daejeon, Republic of Korea. kminkyu@cnu.ac.kr.
- Stem Cell Research Team, MK Biotech Inc, Yuseong-Gu, Daejeon, Republic of Korea. kminkyu@cnu.ac.kr.
Zitieren
APA
Kulatunga, D. C. M., Ranaraja, U., Kim, E. Y., Ji, K., Choi, H. Y., Yoon, J., Park, K., & Kim, M. K. (2026). Engineered APP C-terminus Alters Its Native Transcript Dynamics in Differentiated SH-SY5Y-Derived Neurons. Molecular Neurobiology, 63(1). https://doi.org/10.1007/s12035-026-05928-3
Vancouver
Kulatunga DCM, Ranaraja U, Kim EY, Ji K, Choi HY, Yoon J, et al. Engineered APP C-terminus Alters Its Native Transcript Dynamics in Differentiated SH-SY5Y-Derived Neurons. Molecular Neurobiology. 2026;63(1). doi:10.1007/s12035-026-05928-3
BibTeX
@article{Kulatunga2026,
author = {Kulatunga, D Chanuka M and Ranaraja, Umanthi and Kim, Eun Young and Ji, Kukbin and Choi, Ho Yong and Yoon, JaeHyeok and Park, Kangsun and Kim, Min Kyu},
title = {Engineered APP C-terminus Alters Its Native Transcript Dynamics in Differentiated SH-SY5Y-Derived Neurons},
journal = {Molecular Neurobiology},
year = {2026},
volume = {63},
number = {1},
doi = {10.1007/s12035-026-05928-3}
}
EUVIMED